Search

This work aims to demonstrate that the Fe 2 O 3 nanocrystals' adsorptive and photocatalytic properties can be adjusted by exposing the crystal facets that are functionalized. To this end, cube- and disc-like structures were synthesized using a metal ion-mediated hydrothermal route. Thereafter, some of the samples were annealed at 500 °C for 3 h. Our paper combines the experimental part with theoretical calculations of the obtained materials' band edge positions. The results reveal that-aside from hematite-the as-synthesized discs also contain γ-FeOOH and β-Fe 2 O 3 phases, which transform into α-Fe 2 O 3 during annealing. The hydrodynamic diameter, zeta potential, and adsorption kinetics measurements show that the cube-like samples exhibit the highest affinity for cationic, whereas the discs have an affinity for anionic dye. Measurements of the wall zeta potential also reveal that annealing the discs modifies their surface state and ability to adsorb molecules. Photocatalytic tests show that the as-synthesized powders have better photocatalytic performance toward methylene blue decomposition than the annealed ones. The observed small changes in the concentration of the MO during illumination result from the energy band structure of the cube-like crystal orientation.

Semiconductor photocatalysis is considered one of the most promising technologies for water purification from toxic organic dyes. However, to reliably evaluate the possibility of using a given material as a photocatalyst, it is crucial to investigate not only the photocatalytic activity but also its affinity towards various dyes and reusability. In this work, we studied the adsorptive/photocatalytic properties of hollow-spherical raspberry-like SnO 2 and its SnO 2 /SnS 2 heterostructures that were obtained via a chemical conversion method using three different concentrations of a sulfide precursor (thioacetamide). The adsorptive/photocatalytic properties of the samples towards cationic rhodamine B (RhB) and anionic indigo carmine (IC) were analyzed using uncommon wall zeta potential measurements, hydrodynamic diameter studies, and adsorption/photodecomposition tests. Moreover, after conducting cyclic experiments, we investigated the (micro)structural changes of the reused photocatalysts by scanning electron microscopy and Fourier-transform infrared spectroscopy. The obtained results revealed that the sensitization of SnO 2 resulted not only in the significantly enhanced photocatalytic performance of the heterostructures, but also completely changed their affinity towards dyes. Furthermore, despite the seemingly best photocatalytic performance, the sample with the highest SnS 2 content was unstable due to its (micro)structure. This work demonstrates that dye adsorption/desorption processes may overlap the results of cyclic photodecomposition kinetics.

OCTN2 (SLC22A5) is an organic cation/carnitine transporter belonging to the solute carrier transporters (SLC) family. OCTN2 is ubiquitously expressed and its presence was shown in various brain cells, including the endothelial cells forming blood-brain barrier, where it was mainly detected at abluminal membrane and in proximity of tight junctions (TJ). Since OCTN2 contains a PDZ-binding domain, the present study was focused on a possible role of transporter interaction with a TJ-associated protein ZO-1, containing PDZ domains and detected in rat Octn2 proteome. We showed previously that activation of protein kinase C (PKC) in rat astrocytes regulates Octn2 surface presence and activity. Regulation of a wild type Octn2 and its deletion mutant without a PDZ binding motif were studied in heterologous expression system in HEK293 cells. Plasma membrane presence of overexpressed Octn2 did not depend on either PKC activation or presence of PDZ-binding motif, anyhow, as assayed in proximity ligation assay, the truncation of PDZ binding motif resulted in a strongly diminished Octn2/ZO-1 interaction and in a decreased transporter activity. The same effects on Octn2 activity were detected upon PKC activation, what correlated with ZO-1 phosphorylation. It is postulated that ZO-1, when not phosphorylated by PKC, keeps Octn2 in an active state, while elimination of this binding in ΔPDZ mutant or after ZO-1 phosphorylation leads to diminution of Octn2 activity., (Copyright © 2017 Elsevier B.V. All rights reserved.)

Carnitine (3-hydroxy-4-trimethylammoniobutyrate) is necessary for transfer of fatty acids through the inner mitochondrial membrane. Carnitine, not synthesized in the brain, is delivered there through the strongly polarized blood-brain barrier (BBB). Expression and presence of two carnitine transporters - organic cation/carnitine transporter (OCTN2) and amino acid transporter B(0,+) (ATB(0,+)) have been demonstrated previously in an in vitro model of the BBB. Due to potential protein kinase C (PKC) phosphorylation sites within ATB(0,+) sequence, the present study verified effects of this kinase on transporter function and localization in the BBB. ATB(0,+) can be regulated by estrogen receptor α and up-regulated in vitro, therefore its presence in vivo was verified with the transmission electron microscopy. The analyses of brain slices demonstrated ATB(0,+) luminal localization in brain capillaries, confirmed by biotinylation experiments in an in vitro model of the BBB. Brain capillary endothelial cells were shown to control carnitine gradient. ATB(0,+) was phosphorylated by PKC, what correlated with inhibition of carnitine transport. PKC activation did not change the amount of ATB(0,+) present in the apical membrane of brain endothelial cells, but resulted in transporter exclusion from raft microdomains. ATB(0,+) inactivation by a lateral movement in plasma membrane after transporter phosphorylation has been postulated., (Copyright © 2014 Elsevier Inc. All rights reserved.)

OCTN2--the Organic Cation Transporter Novel family member 2 (SLC22A5) is known to be a xenobiotic/drug transporter. It transports as well carnitine--a compound necessary for oxidation of fatty acids and mutations of its gene cause primary carnitine deficiency. Octn2 regulation by protein kinase C (PKC) was studied in rat astrocytes--cells in which β-oxidation takes place in the brain. Activation of PKC with phorbol ester stimulated L-carnitine transport and increased cell surface presence of the transporter, although no PKC-specific phosphorylation of Octn2 could be detected. PKC activation resulted in an augmented Octn2 presence in cholesterol/sphingolipid-rich microdomains of plasma membrane (rafts) and increased co-precipitation of Octn2 with raft-proteins, caveolin-1 and flotillin-1. Deletion of potential caveolin-1 binding motifs pointed to amino acids 14-22 and 447-454 as the caveolin-1 binding sites within Octn2 sequence. A direct interaction of Octn2 with caveolin-1 in astrocytes upon PKC activation was detected by proximity ligation assay, while such an interaction was excluded in case of flotillin-1. Functioning of a multi-protein complex regulated by PKC has been postulated in rOctn2 trafficking to the cell surface, a process which could be important both under physiological conditions, when carnitine facilitates fatty acids catabolism and controls free Coenzyme A pool as well as in pathology, when transport of several drugs can induce secondary carnitine deficiency.